Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil PCA after gynecological laparoscopic surgery
ChiCTR2400090797Phase 4Not yet recruiting
- Sponsor
- Qionglai Medical Center Hospital
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine and sufentanil in postoperative pain (4 arms), sponsored by Qionglai Medical Center Hospital. Primary endpoint: Pain score. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400090797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090797.